Bilastine - CAS 202189-78-4
Catalog number:
Not Intended for Therapeutic Use. For research use only.
Histamine Receptor
Bilastine is a novel, nonsedating H1-antihistamine developed for symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria.
Publictions citing BOC Sciences Products
  • >> More
Bilastine, trade name Bilaxten
1. Comparative inhibition by bilastine and cetirizine of histamine-induced wheal and flare responses in humans
Martin K. Church. Inflamm. Res. (2011) 60:1107–1112
Early clinical trials have also shown bilastine to be a potent and effective H1-antihistamine. In a study of 525 patients with chronic idiopathic urticaria, bilastine 20 mg once daily significantly (P<0.001 compared with pla- cebo) relieved the symptoms. Furthermore, the overall efficacy results demonstrated that bilastine was of similar efficacy to levocetirizine. In the nose, a double-blind cross-over study in which 75 allergic volunteers were challenged with grass pollen in the Vienna Challenge Chamber showed bilastine to be equally effective as cetirizine and fexofenadine but the results obtained suggest that it has a longer duration than fexofenadine, while in two 14-day trials in seasonal allergic rhinitis, bilastine was shown to be of similar efficacy to daily dosage with 10 mg cetirizine and 5 mg desloratadine.
2. Allergic Conjunctivitis and the Impact of Allergic Rhinitis
Leonard Bielory. Curr Allergy Asthma Rep (2010) 10:122–134
Antihistamines: Bilastine and Bepotastine Recent clinical data suggest an ocular and nasal allergy efficacy profile for bilastine, a new oral antihistamine, similar to that of established oral antihistamines, including desloratadine and cetirizine. In addition, another oral antihistamine agent, bepotastine, was shown to be effective and well-tolerated in patients with Japanese cedar allergen–induced symptoms in an exposure chamber and was recently approved in the United States in an ophthalmic formulation with a very similar profile to those of olopatadine and epinastine.
3. New Therapies for Allergic Rhinitis
Fulvio Braido & Francesca Sclifò & Matteo Ferrando & Giorgio Walter Canonica. Curr Allergy Asthma Rep (2014) 14:422
Bilastine, a new nonsedating H1 receptor inverse agonist, belongs to the piperidine class along with loratadine, desloratadine, and fexofenadine. In vitro studies have shown that bilastine has a high specific affinity for the H1 receptor but no or very low affinity for 30 other tested receptors. This affinity for the H1 receptor is three and six times higher than for cetirizine and fexofenadine, respectively. Bilastine behaves as an H1 mixed antagonist (competitive up to 33 nM; not competitive from 100 nM), as it is 5.5 times more powerful than cetirizine as a competitive antagonist and 10 times more powerful as a noncompetitive antagonist. The effectiveness of bilastine is comparable to that of desloratadine. Besides its H1 antagonism, bilastine has also demonstrated anti-inflammatory properties, including inhibiting the release of proinflammatory cytokines such as IL-4 and tumor necrosis factor-α. Furthermore, in vivo studies in rats demonstrated a significant reduction in histamine-stimulated endothelial permeability, microvascular extravasation, and inhibition of smooth muscular contraction and bronchospasm times that of cetirizine.
4. Integration of preclinical and clinical knowledge to predict intravenous PK in human: Bilastine case study
Valvanera Vozmediano • Ignacio Ortega • John C. Lukas • Ana Gonzalo • Monica Rodriguez • Maria Luisa Lucero. Eur J Drug Metab Pharmacokinet (2014) 39:33–41
First PK modeling was performed for the i.v. and p.o. data in animals alone. Two compartmental representations best described the kinetics of bilastine in animals. The results of Jauregizar et al. (2009) were applied for p.o. bilastine in man. The PK parameters for all species are listed in Table 3 (for p.o. in rat, dog and man and for i.v. in rat and dog). Table 3 also lists the protein binding fraction (fu) for bilastine in these three species.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Histamine Receptor Products

(CAS: 101189-47-3)

CP66,948 is a histamine H2-receptor antagonist. It has gastric antisecretory activity and mucosal protective properties.

CAS 68-88-2 Hydroxyzine

(CAS: 68-88-2)

Hydroxyzine is a histamine H1-receptor antagonist.

CAS 82-93-9 Chlorcyclizine

(CAS: 82-93-9)

Chlorcyclizine is a first-generation Histamine Receptor antagonist of the phenylpiperazine class. It can be used primarily to treat allergy symptoms such as rhi...

CAS 13461-01-3 aceprometazine

(CAS: 13461-01-3)

Aceprometazine is a Histamine H1 receptor antagonist as an approved drug. It can be used in combination with meprobamate for the treatment of sleep disorders su...

CAS 66357-59-3 Ranitidine

(CAS: 66357-59-3)

Ranitidine is a histamine H2-receptor antagonist that inhibits stomach acid production. It is commonly used in treatment of peptic ulcer disease and gastroesoph...

Famotine hydrochloride
(CAS: 10500-82-0)

Famotine hydrochloride is a histamine H2 receptor antagonist. lt has no effect on the cytochrome P450 enzyme system, and does not appear to interact with other ...

CAS 132-20-7 Pheniramine Maleate

Pheniramine Maleate
(CAS: 132-20-7)

Pheniramine Maleate is an antihistamine with anticholinergic properties used to treat allergic conditions such as hay fever or urticaria.

CAS 86-22-6 brompheniramine

(CAS: 86-22-6)

Brompheniramine an antihistamine drug.It belongs to the propylamine class. It can be used for the treatment of the symptoms of the common cold and allergic rhin...

CAS 135-87-5 Piperoxan.Hcl

(CAS: 135-87-5)

Piperoxan is an antihistamine drug which is derived from benzodioxan. At first it was investigated by Fourneau as an α-adrenergic-blocking agent, then they foun...

CAS 85604-00-8 Zaltidine

(CAS: 85604-00-8)

Zaltidine is an effective but hepatotoxic H2-receptor antagonist. It has higher incidence of hepatic damage than with commonly used H2-receptor antagonists. It ...

CAS 544707-19-9 JNJ10181457 dihydrochloride

JNJ10181457 dihydrochloride
(CAS: 544707-19-9)

JNJ10181457 dihydrochloride is a selective non-imidazole brain penetrant histamine H3 receptor antagonist with pKi values of 8.15 and 8.93 for rat and human H3 ...

CAS 76239-32-2 KP136

(CAS: 76239-32-2)

KP136, an antiallergic agent, remarkably inhibited the passive cutaneous anaphylaxis (PCA) with intravenous and oral dosing. KP-136 is an oral potent inhibitor ...

(CAS: 1905481-36-8)

KDM5A-IN-1, a pyrrolidine amide compound, is an inhibitor histone demethylases.

CAS 903576-44-3 BF 2649

BF 2649
(CAS: 903576-44-3)

Pitolisant hydrochloride is an antagonist of the histamine H3 receptor, which is used for the treatment of narcolepsy with or without cataplexy in adult patient...

CAS 147084-10-4 Alcaftadine

(CAS: 147084-10-4)

Alcaftadine(R89674) is a H1 histamine receptor antagonist, which is used to prevent eye irritation brought on by allergic conjunctivitis.

CAS 84-96-8 Trimeprazine

(CAS: 84-96-8)

Alimemazine is a phenothiazine derivative as a Histamine Receptor antagonist. It can be used as an antipruritic . It also acts as a sedative, hypnotic, and anti...

CAS 147-24-0 Diphenhydramine HCl

Diphenhydramine HCl
(CAS: 147-24-0)

Diphenhydramine HCl (Benadryl), a histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a ...

(CAS: 460746-46-7)

ABT-239 is a novel, highly efficacious, non-imidazole class of H3R antagonist has been investigated as a treatment for ADHD, Alzheimer's disease, and schizophr...

(CAS: 103294-47-9)

LY-150310 is a histamine H1-receptor antagonist. It could alter prostanoid concentrations in vitro and in vivo.

CAS 1028327-66-3 VUF10460

(CAS: 1028327-66-3)

VUF10460 is a specific non-imidazole histamine H4 receptor agonist (pKi= 7.46, 8.22 for rat H4 receptor and human H4 receptor respectively) with 50-fold selecti...

Chemical Structure

CAS 202189-78-4 Bilastine

Quick Inquiry

Verification code

Featured Items